Skip to Content

Workers’ Compensation Board

WCB Information Related To Novel Coronavirus (COVID-19)

New York State
Workers' Compensation Board
OFFICE OF THE CHAIR
328 State Street  Schenectady, New York 12305
Governor Andrew M. Cuomo


Subject No. 046-1234

Temporary Suspension of Dr. Tameshwar Ammar

Authorization No. 188169-7W

Date: November 21, 2019

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised her authority to temporarily suspend Dr. Tameshwar Ammar’s authorization to treat injured workers within the New York State workers’ compensation system effective November 21, 2019. Dr. Ammar's last known business address is:

55 Bryant Avenue, Suite 202
Roslyn, New York 11576-1139

The Chair’s designee’s investigation has revealed that the New York State Department of Health, State Board for Professional Medical Conduct (BPMC) has issued Commissioner’s Order of Summary Action # 19-279, wherein Dr. Ammar was ordered to discontinue or refrain from practicing medicine in the State of New York or from practicing in any setting under the authority of his New York license, based on allegations that he knowingly and intentionally conspired to distribute, and possessed with intent to distribute, a controlled substance, and that he on more than one occasion did knowingly and intentionally distribute one or more substances containing oxycodone.

Therefore, the Chair believes that Dr. Ammar may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.

Dr. Ammar is prohibited from rendering treatment and care to injured workers and from conducting reviews of records regarding variance requests pursuant to 12 NYCRR § 324.3(b)(2)(ii)(a) while his authorization is temporarily suspended. Reports submitted by Dr. Ammar for services rendered prior to November 21, 2019 are valid but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Ammar for services rendered prior to November 21, 2019, should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.

 

Clarissa M. Rodriguez
Chair